Inhibition of HSP90 S-nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway.
Xiyue ZhangYihua ZhangQing MiaoZhiguang ShiLulu HuShangmin LiuJie GaoShuang ZhaoHongshan ChenZhengrong HuangYi HanYong JiLi-Ping XiePublished in: British journal of pharmacology (2021)
Genetic or pharmacological inhibition of SNO-HSP90 mitigates fibrosis through blocking the TGFβ/SMAD3 signalling pathway, providing a potential therapy for cardiac remodelling.